Works by Baker, Sharyn D.

Results: 48

In Memoriam Michelle A. Rudek (1972–2023).

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 2, p. 181, doi. 10.1002/cpt.3137

By:

Baker, Sharyn D.;
Figg, William D.

Publication type:

Article

Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1.

Published in:

Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 1, p. 227, doi. 10.1002/cpt.1588

By:

Chen, Mingqing;
Neul, Claudia;
Schaeffeler, Elke;
Frisch, Franziska;
Winter, Stefan;
Schwab, Matthias;
Koepsell, Hermann;
Hu, Shuiying;
Laufer, Stefan;
Baker, Sharyn D.;
Sparreboom, Alex;
Nies, Anne T.

Publication type:

Article

A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities.

Published in:

Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091933

By:

Li, Yang;
Jin, Yan;
Taheri, Hanieh;
Schmidt, Keith T.;
Gibson, Alice A.;
Buck, Stefan A. J.;
Eisenmann, Eric D.;
Mathijssen, Ron H. J.;
Figg, William D.;
Baker, Sharyn D.;
Sparreboom, Alex;
Hu, Shuiying

Publication type:

Article

Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination.

Published in:

Pharmaceutics, 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/pharmaceutics14040694

By:

Eisenmann, Eric D.;
Garrison, Dominique A.;
Talebi, Zahra;
Jin, Yan;
Silvaroli, Josie A.;
Kim, Jin-Gyu;
Sparreboom, Alex;
Savona, Michael R.;
Mims, Alice S.;
Baker, Sharyn D.

Publication type:

Article

Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors.

Published in:

Pharmaceutics, 2020, v. 12, n. 9, p. 856, doi. 10.3390/pharmaceutics12090856

By:

Garrison, Dominique A.;
Talebi, Zahra;
Eisenmann, Eric D.;
Sparreboom, Alex;
Baker, Sharyn D.

Publication type:

Article

Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib.

Published in:

Pharmaceutics, 2020, v. 12, n. 9, p. 788, doi. 10.3390/pharmaceutics12090788

By:

Hussaarts, Koen G. A. M.;
van Doorn, Leni;
Eechoute, Karel;
Damman, Jeffrey;
Fu, Qiang;
van Doorn, Nadia;
Eisenmann, Eric D.;
Gibson, Alice A.;
Oomen-de Hoop, Esther;
de Bruijn, Peter;
Baker, Sharyn D.;
Koolen, Stijn L. W.;
van Gelder, Teun;
van Leeuwen, Roelof W. F.;
Mathijssen, Ron H. J.;
Sparreboom, Alex;
Bins, Sander

Publication type:

Article

A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03).

Published in:

2017

By:

Cooper, Todd M.;
Sison, Edward Allan Racela;
Baker, Sharyn D.;
Li, Lie;
Ahmed, Amina;
Trippett, Tanya;
Gore, Lia;
Macy, Margaret E.;
Narendran, Aru;
August, Keith;
Absalon, Michael J.;
Boklan, Jessica;
Pollard, Jessica;
Magoon, Daniel;
Brown, Patrick A.

Publication type:

journal article

Alternative formulations of sorafenib for use in children.

Published in:

Pediatric Blood & Cancer, 2013, v. 60, n. 10, p. 1642, doi. 10.1002/pbc.24619

By:

Navid, Fariba;
Christensen, Robbin;
Inaba, Hiroto;
Li, Lie;
Chen, Zhaoyuan;
Cai, Xiangjun;
Regel, Joshua;
Baker, Sharyn D.

Publication type:

Article

Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia.

Published in:

2018

By:

van Oosterwijk, Jolieke G.;
Buelow, Daelynn R.;
Drenberg, Christina D.;
Vasilyeva, Aksana;
Lie Li;
Lei Shi;
Yong-Dong Wang;
Finkelstein, David;
Shurtleff, Sheila A.;
Janke, Laura J.;
Pounds, Stanley;
Rubnitz, Jeffrey E.;
Hiroto Inaba;
Pabla, Navjotsingh;
Baker, Sharyn D.;
Li, Lie;
Shi, Lei;
Wang, Yong-Dong;
Inaba, Hiroto

Publication type:

journal article

Evaluation of artemisinins for the treatment of acute myeloid leukemia.

Published in:

2016

By:

Drenberg, Christina;
Buaboonnam, Jassada;
Orwick, Shelley;
Hu, Shuiying;
Li, Lie;
Fan, Yiping;
Shelat, Anang;
Guy, R.;
Rubnitz, Jeffrey;
Baker, Sharyn;
Drenberg, Christina D;
Orwick, Shelley J;
Shelat, Anang A;
Guy, R Kiplin;
Baker, Sharyn D

Publication type:

journal article

Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice.

Published in:

2016

By:

Edginton, Andrea;
Zimmerman, Eric;
Vasilyeva, Aksana;
Baker, Sharyn;
Panetta, John;
Edginton, Andrea N;
Zimmerman, Eric I;
Baker, Sharyn D;
Panetta, John C

Publication type:

journal article

Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 3, p. 423, doi. 10.1007/s00280-007-0485-9

By:

Jimeno, Antonio;
Rudek, Michelle A.;
Purcell, Thomas;
Laheru, Daniel A.;
Messersmith, Wells A.;
Dancey, Janet;
Carducci, Michael A.;
Baker, Sharyn D.;
Hidalgo, Manuel;
Donehower, Ross C.

Publication type:

Article

Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice.

Published in:

Pharmacology Research & Perspectives, 2019, v. 7, n. 6, p. 1, doi. 10.1002/prp2.534

By:

Anderson, Jason T.;
Shuiying Hu;
Qiang Fu;
Baker, Sharyn D.;
Sparreboom, Alex

Publication type:

Article

Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutation.

Published in:

Leukemia & Lymphoma, 2017, v. 58, n. 1, p. 247, doi. 10.1080/10428194.2016.1187272

By:

Drenberg, Christina D.;
Buelow, Daelynn R.;
Pounds, Stanley B.;
Wang, Yong-Dong;
Finkelstein, David;
Rahija, Richard J.;
Shurtleff, Sheila A.;
Rubnitz, Jeffrey E.;
Inaba, Hiroto;
Gruber, Tanja A.;
Klco, Jeffery M.;
Baker, Sharyn D.

Publication type:

Article

Clinical significance of in vivo cytarabine-induced gene expression signature in AML.

Published in:

Leukemia & Lymphoma, 2016, v. 57, n. 4, p. 909, doi. 10.3109/10428194.2015.1086918

By:

Lamba, Jatinder K.;
Pounds, Stanley;
Cao, Xueyuan;
Crews, Kristine R.;
Cogle, Christopher R.;
Bhise, Neha;
Raimondi, Susana C.;
Downing, James R.;
Baker, Sharyn D.;
Ribeiro, Raul C.;
Rubnitz, Jeffrey E.

Publication type:

Article

Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML.

Published in:

Investigational New Drugs, 2020, v. 38, n. 2, p. 340, doi. 10.1007/s10637-019-00786-4

By:

Jeon, Jae Yoon;
Zhao, Qiuhong;
Buelow, Daelynn R.;
Phelps, Mitch;
Walker, Alison R.;
Mims, Alice S.;
Vasu, Sumithira;
Behbehani, Gregory;
Blachly, James;
Blum, William;
Klisovic, Rebecca B.;
Byrd, John C.;
Garzon, Ramiro;
Baker, Sharyn D.;
Bhatnagar, Bhavana

Publication type:

Article

In memoriam Michelle A. Rudek (1972–2023).

Published in:

CTS: Clinical & Translational Science, 2024, v. 17, n. 1, p. 1, doi. 10.1111/cts.13705

By:

Baker, Sharyn D.;
Figg, William D.

Publication type:

Article

DNA methyltransferase inhibitor exposure–response: Challenges and opportunities.

Published in:

CTS: Clinical & Translational Science, 2023, v. 16, n. 8, p. 1309, doi. 10.1111/cts.13548

By:

Kagan, Amanda B.;
Garrison, Dominique A.;
Anders, Nicole M.;
Webster, Jonathan A.;
Baker, Sharyn D.;
Yegnasubramanian, Srinivasan;
Rudek, Michelle A.

Publication type:

Article

DNA Methylation‐Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia.

Published in:

CTS: Clinical & Translational Science, 2021, v. 14, n. 1, p. 137, doi. 10.1111/cts.12861

By:

Buelow, Daelynn R.;
Anderson, Jason T.;
Pounds, Stanley B.;
Shi, Lei;
Lamba, Jatinder K.;
Hu, Shuiying;
Gibson, Alice A.;
Goodwin, Emily A.;
Sparreboom, Alex;
Baker, Sharyn D.

Publication type:

Article

Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3‐ITD AML.

Published in:

CTS: Clinical & Translational Science, 2019, v. 12, n. 6, p. 641, doi. 10.1111/cts.12669

By:

Buelow, Daelynn R.;
Pounds, Stanley B.;
Wang, Yong‐Dong;
Shi, Lei;
Li, Yongjin;
Finkelstein, David;
Shurtleff, Sheila;
Neale, Geoffrey;
Inaba, Hiroto;
Ribeiro, Raul C.;
Palumbo, Reid;
Garrison, Dominique;
Orwick, Shelley J.;
Blachly, James S.;
Kroll, Karl;
Byrd, John C.;
Gruber, Tanja A.;
Rubnitz, Jeffrey E.;
Baker, Sharyn D.

Publication type:

Article

Interaction Between Sex and Organic Anion‐Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib‐N‐Oxide and Regorafenib‐Glucuronide in Mice.

Published in:

CTS: Clinical & Translational Science, 2019, v. 12, n. 4, p. 400, doi. 10.1111/cts.12630

By:

Fu, Qiang;
Chen, Mingqing;
Anderson, Jason T.;
Sun, Xinxin;
Hu, Shuiying;
Sparreboom, Alex;
Baker, Sharyn D.

Publication type:

Article

Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabine.

Published in:

Cancer (0008543X), 2017, v. 123, n. 18, p. 3602, doi. 10.1002/cncr.30762

By:

Karol, Seth E.;
Yang, Wenjian;
Smith, Colton;
Cheng, Cheng;
Stewart, Clinton F.;
Baker, Sharyn D.;
Sandlund, John T.;
Rubnitz, Jeffrey E.;
Bishop, Michael W.;
Pappo, Alberto S.;
Jeha, Sima;
Pui, Ching-Hon;
Relling, Mary V.

Publication type:

Article

A method for determination of dimethyl benzoylphenyl urea (BPU) in human plasma by using LC/UV.

Published in:

Biomedical Chromatography, 2004, v. 18, n. 5, p. 282, doi. 10.1002/bmc.314

By:

Rudek, Michelle A.;
Zabelina, Yelena;
Zhao, Ming;
Wolff, Antonio C.;
Baker, Sharyn D.

Publication type:

Article

Boosting the oral bioavailability of anticancer drugs through intentional drug–drug interactions.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, p. 23, doi. 10.1111/bcpt.13623

By:

Eisenmann, Eric D.;
Talebi, Zahra;
Sparreboom, Alex;
Baker, Sharyn D.

Publication type:

Article

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion.

Published in:

Cancers, 2023, v. 15, n. 1, p. 29, doi. 10.3390/cancers15010029

By:

Eisenmann, Eric D.;
Stromatt, Jack C.;
Fobare, Sydney;
Huang, Kevin M.;
Buelow, Daelynn R.;
Orwick, Shelley;
Jeon, Jae Yoon;
Weber, Robert H.;
Larsen, Bill;
Mims, Alice S.;
Hertlein, Erin;
Byrd, John C.;
Baker, Sharyn D.

Publication type:

Article

TAK1 is a Regulator of Sorafenib‐induced Keratinocyte Toxicity.

Published in:

FASEB Journal, 2013, v. 27, p. 657.1, doi. 10.1096/fasebj.27.1_supplement.657.1

By:

Zimmerman, Eric I;
Gibson, Alice A;
Hu, Shuiying;
Berk, Jeffrey;
Orwick, Shelley;
Sparreboom, Alex;
Baker, Sharyn D

Publication type:

Article

Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3 -ITD mutations.

Published in:

Frontiers in Hematology, 2025, p. 1, doi. 10.3389/frhem.2025.1554764

By:

Bhatnagar, Bhavana;
Buelow, Daelynn R.;
Dvorak-Kornaus, Kaitlyn M.;
Orwick, Shelley J.;
Yoon Jeon, Jae;
Talebi, Zahra;
Ruppert, Amy S.;
Blachly, James S.;
Borate, Uma;
Baker, Sharyn D.

Publication type:

Article

Clinical Pharmacokinetics of Docetaxel: Recent Developments.

Published in:

Clinical Pharmacokinetics, 2006, v. 45, n. 3, p. 235, doi. 10.2165/00003088-200645030-00002

By:

Baker, Sharyn D.;
Sparreboom, Alex;
Verweij, Jaap

Publication type:

Article

A kinome-wide screen identifies a CDKL5-SOX9 regulatory axis in epithelial cell death and kidney injury.

Published in:

Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15638-6

By:

Kim, Ji Young;
Bai, Yuntao;
Jayne, Laura A.;
Hector, Ralph D.;
Persaud, Avinash K.;
Ong, Su Sien;
Rojesh, Shreshtha;
Raj, Radhika;
Feng, Mei Ji He Ho;
Chung, Sangwoon;
Cianciolo, Rachel E.;
Christman, John W.;
Campbell, Moray J.;
Gardner, David S.;
Baker, Sharyn D.;
Sparreboom, Alex;
Govindarajan, Rajgopal;
Singh, Harpreet;
Chen, Taosheng;
Poi, Ming

Publication type:

Article

Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51.

Published in:

PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079106

By:

Xie, Chengzhi;
Drenberg, Christina;
Edwards, Holly;
Caldwell, J. Timothy;
Chen, Wei;
Inaba, Hiroto;
Xu, Xuelian;
Buck, Steven A.;
Taub, Jeffrey W.;
Baker, Sharyn D.;
Ge, Yubin

Publication type:

Article

Kinase Inhibitors: The Reality Behind the Success.

Published in:

Clinical Pharmacology & Therapeutics, 2017, v. 102, n. 5, p. 726, doi. 10.1002/cpt.815

By:

Jeon, Jae Yoon;
Sparreboom, Alex;
Baker, Sharyn D.

Publication type:

Article

Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group.

Published in:

Clinical Pharmacology & Therapeutics, 2015, v. 98, n. 3, p. 266, doi. 10.1002/cpt.176

By:

Brouwer, KLR;
Aleksunes, LM;
Brandys, B;
Giacoia, GP;
Knipp, G;
Lukacova, V;
Meibohm, B;
Nigam, SK;
Rieder, M;
de Wildt, SN;
Abdel‐Rahman, Susan;
Aleksunse, Lauren M.;
Baker, Sharyn D.;
Bolger, Michael B.;
Brandys, Barbara;
Brouwer, Kim L. R.;
Bush, Kevin T.;
Clancy, Barbara;
DeSesso, John M.;
Fisher, Jeffery

Publication type:

Article

Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib<sup>*</sup>.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 2, p. 192, doi. 10.1016/j.clpt.2006.05.003

By:

Gardner, Erin R.;
Burger, Herman;
van Schaik, Ron H.;
van Oosterom, Allan T.;
de Bruijn, Ernst A.;
Guetens, Gunther;
Prenen, Hans;
de Jong, Floris A.;
Baker, Sharyn D.;
Bates, Susan E.;
Figg, William D.;
Verweij, Jaap;
Sparreboom, Alex;
Nooter, Kees

Publication type:

Article

Relationship of systemic exposure to unbound docetaxel and neutropenia.

Published in:

Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 43, doi. 10.1016/j.clpt.2004.09.005

By:

Baker, Sharyn D.;
Li, Jing;
ten Tije, Albert J.;
Figg, William D.;
Graveland, Wilfried;
Verweij, Jaap;
Sparreboom, Alex

Publication type:

Article

Effect of Cytochrome P450 3A4 Inhibition on the Pharmacokinetics of Docetaxel.

Published in:

Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 5, p. 448, doi. 10.1016/j.clpt.2004.01.001

By:

Engels, Frederike K.;
ten Tije, Albert J.;
Baker, Sharyn D.;
Lee, Carlton K. K.;
Loos, Walter J.;
Vulto, Arnold G.;
Verweij, Jaap;
Sparreboom, Alex

Publication type:

Article

Disposition of polyoxyethylated excipients in humans: Implications for drug safety and formulation approaches.

Published in:

Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 5, p. 509, doi. 10.1016/j.clpt.2003.08.004

By:

ten Tije, Albert J.;
Loos, Walter J.;
Verweij, Jaap;
Baker, Sharyn D.;
Dinh, Kimberly;
Figg, William D.;
Sparreboom, Alex

Publication type:

Article

Clinical pharmacokinetics of unbound docetaxel: Role of polysorbate 80 and serum proteins.

Published in:

Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 4, p. 364, doi. 10.1016/S0009-9236(03)00222-4

By:

Loos, Walter J.;
Baker, Sharyn D.;
Verweij, Jaap;
Boonstra, Joke G.;
Sparreboom, Alex

Publication type:

Article

Temozolomide in Patients with Advanced Cancer: Phase I and Pharmacokinetic Study.

Published in:

Pharmacotherapy, 2004, v. 24, n. 1, p. 16, doi. 10.1592/phco.24.1.16.34800

By:

Rudek, Michelle A.;
Donehower, Ross C.;
Statkevich, Paul;
Batra, Vijay K.;
Culler, David L.;
Baker, Sharyn D.

Publication type:

Article

CREBBP mutations in relapsed acute lymphoblastic leukaemia.

Published in:

Nature, 2011, v. 471, n. 7337, p. 235, doi. 10.1038/nature09727

By:

Mullighan, Charles G.;
Jinghui Zhang;
Kasper, Lawryn H.;
Lerach, Stephanie;
Payne-Turner, Debbie;
Phillips, Letha A.;
Heatley, Sue L.;
Holmfeldt, Linda;
Collins-Underwood, J. Racquel;
Jing Ma;
Buetow, Kenneth H.;
Ching-Hon Pui;
Baker, Sharyn D.;
Brindle, Paul K.;
Downing, James R.

Publication type:

Article

Activity of the Multikinase Inhibitor Sorafenib in Combination With Cytarabine in Acute Myeloid Leukemia.

Published in:

JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 11, p. 893, doi. 10.1093/jnci/djr107

By:

Shuiying Hu;
Hongmei Niu;
Inaba, Hiroto;
Orwick, Shelley;
Rose, Charles;
Panetta, John C.;
Shengping Yang;
Pounds, Stanley;
Yiping Fan;
Calabrese, Christopher;
Rehg, Jerold E.;
Campana, Dario;
Rubnitz, Jeffrey E.;
Baker, Sharyn D.

Publication type:

Article

Pharmacogenetics of ABCG2 and adverse reactions to gefitinib.

Published in:

2006

By:

Cusatis, George;
Gregorc, Vanesa;
Jing Li;
Spreafico, Anna;
Ingersoll, Roxann G.;
Verweu, Jaap;
Ludovini, Vienna;
Villa, Eugenio;
Hidalgo, Manuel;
Sparreboom, Alex;
Baker, Sharyn D.;
Li, Jing;
Verweij, Jaap

Publication type:

journal article

CYP3A Phenotyping Approach to Predict Systemic Exposure to EGFR Tyrosine Kinase Inhibitors.

Published in:

JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 23, p. 1714, doi. 10.1093/jnci/djj466

By:

Jing Li;
Mats O. Karisson;
Brahmer, Julie;
Spitz, Avery;
Ming Zhao;
Hidalgo, Manuel;
Baker, Sharyn D.

Publication type:

Article

Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: A dose escalation and pharmacologic study.

Published in:

Neuro-Oncology, 2005, v. 7, n. 2, p. 177, doi. 10.1215/S1152851704000183

By:

Phuphanich, Surasak;
Baker, Sharyn D.;
Grossman, Stuart A.;
Carson, Kathryn A.;
Gilbert, Mark R.;
Fisher, Joy D.;
Carducci, Michael A.

Publication type:

Article

Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia.

Published in:

Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-019-0821-7

By:

Elgamal, Ola A.;
Mehmood, Abeera;
Jeon, Jae Yoon;
Carmichael, Bridget;
Lehman, Amy;
Orwick, Shelley J.;
Truxall, Jean;
Goettl, Virginia M.;
Wasmuth, Ronni;
Tran, Minh;
Mitchell, Shaneice;
Lapalombella, Rosa;
Eathiraj, Sudharshan;
Schwartz, Brian;
Stegmaier, Kimberly;
Baker, Sharyn D.;
Hertlein, Erin;
Byrd, John C.

Publication type:

Article

Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B.

Published in:

Molecules, 2022, v. 27, n. 20, p. 6815, doi. 10.3390/molecules27206815

By:

Garrison, Dominique A.;
Jin, Yan;
Talebi, Zahra;
Hu, Shuiying;
Sparreboom, Alex;
Baker, Sharyn D.;
Eisenmann, Eric D.

Publication type:

Article

Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.

Published in:

2002

By:

Baker, Sharyn D.;
Jaap Verweij;
Rowinsky, Eric K.;
Donehower, Ross C.;
Schellens, Jan H.M.;
Grochow, Louise B.;
Sparreboom, Alex;
Verweij, Jaap

Publication type:

journal article

Should anticancer drug doses be adjusted in the obese patient?

Published in:

1995

By:

Baker, Sharyn D.;
Grochow, Louise B.

Publication type:

Editorial

A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML.

Published in:

Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09917-0

By:

Drenberg, Christina D.;
Shelat, Anang;
Dang, Jinjun;
Cotton, Anitria;
Orwick, Shelley J.;
Li, Mengyu;
Jeon, Jae Yoon;
Fu, Qiang;
Buelow, Daelynn R.;
Pioso, Marissa;
Hu, Shuiying;
Inaba, Hiroto;
Ribeiro, Raul C.;
Rubnitz, Jeffrey E.;
Gruber, Tanja A.;
Guy, R. Kiplin;
Baker, Sharyn D.

Publication type:

Article